LOS ANGELES, Feb. 14, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with losses related to Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN…